Clinical Trials Directory

Trials / Completed

CompletedNCT04047433

The Occurrence of Single Nucleotide Polymorphism Among Women Who Experienced Obstetric Anal Sphincter Injury

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
93 (actual)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Single-nucleotide polymorphisms (SNP's) in connective tissue components are associated with increased risk of pelvic organ prolapse (POP). The investigators expect to find a difference in SNP's frequency between women who had Obstetric anal sphincter injuries (OASIS) and in the healthy population. The fact that pelvic organ prolapse (POP) and OASIS occurs in the same anatomic region and the well-known association between few SNP's and the risk for POP, suggests for a common pathophysiology.

Detailed description

The perineum consists of skin, muscles and connective tissue. A connective tissue disorder related to POP has been reported in biochemical and molecular studies. OASIS are considered a severe complication of vaginal delivery that may lead to a great deal of morbidity. Familial history is known as a risk factor for OASIS. Currently, there is no established genetic link between connective tissue components and OASIS. Therefore, the investigators assume that studying the genetic predisposition factors of women who experience OASIS, might generate a stronger tool to predict severe occurrence of vaginal laceration. It may also help to consult women before vaginal delivery about the risk of OASIS. The aim of this study is to find an association between genetic variation and increased risk for OASIS.

Conditions

Interventions

TypeNameDescription
GENETICscreening for single nucleotide polymorphismsamples from both arms will be tested for a set of single nucleotide polymorphism
GENETICwhole exome sequencingsamples from arm #1 (women with external anal sphincter) will be tested for identifying specific genetic mutation

Timeline

Start date
2020-09-04
Primary completion
2023-10-05
Completion
2023-10-05
First posted
2019-08-06
Last updated
2025-03-26

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT04047433. Inclusion in this directory is not an endorsement.